Mark N. Gaze

5.9k total citations
166 papers, 3.1k citations indexed

About

Mark N. Gaze is a scholar working on Neurology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark N. Gaze has authored 166 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Neurology, 48 papers in Surgery and 43 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark N. Gaze's work include Neuroblastoma Research and Treatments (77 papers), Glioma Diagnosis and Treatment (29 papers) and Cancer, Hypoxia, and Metabolism (29 papers). Mark N. Gaze is often cited by papers focused on Neuroblastoma Research and Treatments (77 papers), Glioma Diagnosis and Treatment (29 papers) and Cancer, Hypoxia, and Metabolism (29 papers). Mark N. Gaze collaborates with scholars based in United Kingdom, France and Netherlands. Mark N. Gaze's co-authors include J. Gains, R. Mairs, Jamshed Bomanji, Matthew Aldridge, J. A. Wilson, A. G. D. Maran, Robert J. Mairs, V.J. Cowie, Charles Kelly and G.R. Kerr and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mark N. Gaze

156 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark N. Gaze United Kingdom	31	1.2k	912	753	735	673	166	3.1k
Marguerite T. Parisi United States	27	1.1k 0.9×	1.1k 1.2×	412 0.5×	464 0.6×	443 0.7×	126	3.4k
Robert E. Goldsby United States	31	712 0.6×	700 0.8×	617 0.8×	1.5k 2.1×	610 0.9×	94	3.6k
Tejpal Gupta India	33	453 0.4×	1.2k 1.3×	879 1.2×	1.7k 2.3×	355 0.5×	300	4.5k
Henry Cohen United States	25	545 0.4×	731 0.8×	568 0.8×	440 0.6×	262 0.4×	38	2.8k
Sandip Basu India	37	710 0.6×	1.3k 1.4×	1.2k 1.5×	1.4k 1.9×	429 0.6×	364	5.3k
Hélène Pacquement France	36	638 0.5×	437 0.5×	1.1k 1.4×	1.4k 1.9×	279 0.4×	108	4.1k
Jesse J. Jenkins United States	42	1.0k 0.8×	850 0.9×	1.1k 1.4×	1.9k 2.5×	222 0.3×	120	4.3k
Hans Theodor Eich Germany	36	986 0.8×	645 0.7×	1.6k 2.1×	1.5k 2.0×	313 0.5×	256	4.8k
Naofumi Hayabuchi Japan	36	923 0.8×	1.3k 1.4×	583 0.8×	2.2k 3.0×	188 0.3×	208	4.8k
Kathryn E. Dusenbery United States	34	294 0.2×	529 0.6×	1.1k 1.4×	1.0k 1.4×	213 0.3×	126	4.6k

Countries citing papers authored by Mark N. Gaze

Since Specialization

Citations

This map shows the geographic impact of Mark N. Gaze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Gaze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Gaze more than expected).

Fields of papers citing papers by Mark N. Gaze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark N. Gaze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Gaze. The network helps show where Mark N. Gaze may publish in the future.

Co-authorship network of co-authors of Mark N. Gaze

This figure shows the co-authorship network connecting the top 25 collaborators of Mark N. Gaze. A scholar is included among the top collaborators of Mark N. Gaze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark N. Gaze. Mark N. Gaze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gawne, Peter J., Helen E. Bryant, Steven G. DuBois, et al.. (2025). Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better. Journal of Nuclear Medicine. 66(4). 490–496. 1 indexed citations

Schoot, Reineke A., M. Hol, Véronique Minard-Colin, et al.. (2025). Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcoma. European Journal of Endocrinology. 192(1). 25–33.

Fransson, Susanne, Per Grybäck, Anna Djos, et al.. (2024). Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report. Frontiers in Oncology. 14. 1408729–1408729.

Cameron, Alison, Henry Mandeville, Raquel Dávila Fajardo, et al.. (2024). The Impact of Radiation Therapy on Metastatic Rhabdomyosarcoma: Results From the EpSSG MTS 2008 Study. International Journal of Radiation Oncology*Biology*Physics. 121(2). 388–402. 1 indexed citations

Gains, J., et al.. (2024). A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk Neuroblastoma. Clinical Oncology. 36(6). e154–e162.

Gains, J., et al.. (2023). Paediatric radiotherapy in the United Kingdom: an evolving subspecialty and a paradigm for integrated teamworking in oncology. British Journal of Radiology. 97(1153). 21–30. 4 indexed citations

Hol, M., Daniel J. Indelicato, Olga Slater, et al.. (2023). Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study. Pediatric Blood & Cancer. 70(8). e30412–e30412. 1 indexed citations

Hackshaw, Allan, Kate Newbold, Matthew Beasley, et al.. (2023). 2212MO Major secondary outcomes in the multicentre noninferiority randomised trial IoN: Is ablative radioiodine necessary for low-risk differentiated thyroid cancer patients?. Annals of Oncology. 34. S1142–S1142. 3 indexed citations

Boterberg, Tom, Karin Dieckmann, Geert O. Janssens, et al.. (2023). Radical skeletal metastatic site irradiation in high-risk neuroblastoma: systematic review and proposal for a randomised trial. Journal of Cancer Metastasis and Treatment. 1 indexed citations

10.

Howard, Sasha, et al.. (2022). New UK guidelines for differentiated thyroid cancer in children. British journal of surgery. 109(10). 1021–1022. 1 indexed citations

11.

Shankar, Ananth, Tom Kurzawinski, Emma Ross, et al.. (2021). Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma. European Journal of Cancer. 158. 38–46. 14 indexed citations

12.

Slater, Olga, J. Gains, Anna Kelsey, et al.. (2021). Localised rhabdomyosarcoma in infants (<12 months) and young children (12–36 months of age) treated on the EpSSG RMS 2005 study. European Journal of Cancer. 160. 206–214. 13 indexed citations

13.

Bell, Robert M., Amy A. Kirkwood, Darren Hargrave, et al.. (2020). Disseminated Low Grade Glioma in Children and Young Adults. UCL Discovery (University College London). 6(1). 1 indexed citations

14.

Kelly, Sarah M., et al.. (2020). The spleen as an organ at risk in paediatric radiotherapy: A SIOP-Europe Radiation Oncology Working Group report. European Journal of Cancer. 143. 1–10. 18 indexed citations

15.

Guérin, Florent, Timothy Rogers, Véronique Minard‐Colin, et al.. (2019). Outcome of localized liver‐bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft‐Tissue Sarcoma Study Group (EpSSG)‐RMS 2005 study. Pediatric Blood & Cancer. 66(7). e27725–e27725. 12 indexed citations

16.

Noesel, Max M. van, Daniel Orbach, Bernadette Brennan, et al.. (2019). Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS‐2005 prospective study. Pediatric Blood & Cancer. 66(10). e27833–e27833. 42 indexed citations

17.

Lee, Johanna H. van der, Willemijn B. Breunis, Daniel Orbach, et al.. (2017). Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study. Cancer. 124(5). 1016–1024. 24 indexed citations

18.

Saran, Frank, Mark N. Gaze, Sarah Chittenden, et al.. (2007). Dosimetry for Fractionated ¹³¹ I-mIBG Therapies in Patients with Primary Resistant High-Risk Neuroblastoma: Preliminary Results. Cancer Biotherapy and Radiopharmaceuticals. 22(1). 105–112. 42 indexed citations

19.

Armour, Alexis, et al.. (1997). The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro. British Journal of Cancer. 75(4). 470–476. 32 indexed citations

20.

Armour, Alexis, et al.. (1994). Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature. British Journal of Cancer. 70(3). 445–448. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact